Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1953 1
1963 2
1968 1
1991 1
1992 2
1993 1
1996 1
1997 1
1998 1
2000 1
2001 1
2005 1
2006 1
2007 1
2008 2
2010 2
2011 3
2012 4
2013 3
2014 4
2015 4
2016 2
2018 3
2019 3
2020 1
2021 1
2022 1
2023 3
2024 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

47 results

Results by year

Filters applied: . Clear all
Page 1
Single-point and kinetics of peripheral residual disease by mass spectrometry to predict outcome in patients with high-risk smoldering multiple myeloma included in the GEM-CESAR trial.
Puig N, Agulló C, Contreras T, Pérez JJ, Aires I, Calasanz MJ, García-Sanz R, Castro S, Martínez-López J, Rodríguez-Otero P, González-Calle V, González MS, Oriol A, Gutiérrez NC, Ríos-Tamayo R, Rosiñol L, Álvarez MÁ, Bargay J, González-Rodríguez AP, Alegre A, Escalante F, Iñigo MB, De la Rubia J, Teruel AI, De Arriba F, Palomera L, Hernández MT, López-Jiménez J, Reinoso M, García-Mateo A, Ocio EM, Bladé J, Lahuerta JJ, Cedena MT, Paiva B, Miguel JFS, Mateos MV. Puig N, et al. Among authors: reinoso m. Haematologica. 2024 Dec 1;109(12):4056-4066. doi: 10.3324/haematol.2024.285742. Haematologica. 2024. PMID: 38988266 Free PMC article.
Selinexor, daratumumab, bortezomib and dexamethasone for the treatment of patients with relapsed or refractory multiple myeloma: results of the phase II, nonrandomized, multicenter GEM-SELIBORDARA study.
González-Calle V, Rodríguez-Otero P, Sureda A, De Arriba F, Reinoso M, Ribas P, González-Rodríguez AP, González Y, Oriol A, Martínez-López J, González MS, Hernández MT, Sirvent M, Cedena T, Puig N, Paiva B, Bladé J, Lahuerta JJ, San-Miguel JF, Mateos MV. González-Calle V, et al. Among authors: reinoso m. Haematologica. 2024 Jul 1;109(7):2219-2228. doi: 10.3324/haematol.2023.284089. Haematologica. 2024. PMID: 38356463 Free PMC article. Clinical Trial.
[Protein electrophoresis].
REINOSO MA. REINOSO MA. Rev Ecuat Hig Med Trop. 1953;10(1-2):27-50. Rev Ecuat Hig Med Trop. 1953. PMID: 13237605 Spanish. No abstract available.
Association Between Parental Leave and Ophthalmology Resident Physician Performance.
Huh DD, Wang J, Fliotsos MJ, Beal CJ, Boente CS, Wisely CE, De Andrade LM, Lorch AC, Ramanathan S, Reinoso MA, Swamy RN, Waxman EL, Woreta FA, Srikumaran D. Huh DD, et al. Among authors: reinoso ma. JAMA Ophthalmol. 2022 Nov 1;140(11):1066-1075. doi: 10.1001/jamaophthalmol.2022.3778. JAMA Ophthalmol. 2022. PMID: 36173610 Free PMC article.
Gender Differences in Case Volume Among Ophthalmology Residents.
Gong D, Winn BJ, Beal CJ, Blomquist PH, Chen RW, Culican SM, Dagi Glass LR, Domeracki GF, Goshe JM, Jones JK, Khouri AS, Legault GL, Martin TJ, Mitchell KT, Naseri A, Oetting TA, Olson JH, Pettey JH, Reinoso MA, Reynolds AL, Siatkowski RM, SooHoo JR, Sun G, Syed MF, Tao JP, Taravati P, WuDunn D, Al-Aswad LA. Gong D, et al. Among authors: reinoso ma. JAMA Ophthalmol. 2019 Sep 1;137(9):1015-1020. doi: 10.1001/jamaophthalmol.2019.2427. JAMA Ophthalmol. 2019. PMID: 31318390 Free PMC article.
Conformational polymorphism in bicalutamide.
Vega DR, Polla G, Martinez A, Mendioroz E, Reinoso M. Vega DR, et al. Among authors: reinoso m. Int J Pharm. 2007 Jan 10;328(2):112-8. doi: 10.1016/j.ijpharm.2006.08.001. Epub 2006 Aug 8. Int J Pharm. 2007. PMID: 16978811
47 results